Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Takaaki Mizuo"'
Autor:
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO, TSUTOMU MASAKI
Publikováno v:
Anticancer Research. 42:1263-1275
Drug resistance to molecular targeted agents, such as lenvatinib, is an important issue. The aim of this study was to explore the mechanism of lenvatinib resistance and to investigate potential drugs that may improve the treatment of lenvatinib-resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b919d795f4458e8e82399aac10c7557
https://doi.org/10.21873/anticanres.15593
https://doi.org/10.21873/anticanres.15593
Autor:
Ryota, Nakabayashi, Shintaro, Fujihara, Hisakazu, Iwama, Sae, Hamaya, Takaaki, Mizuo, Masahiro, Hirata, Koji, Fujita, Toshiaki, Kono, Daisuke, Namima, Naoki, Fujita, Hiroki, Yamana, Kiyoyuki, Kobayashi, Hideki, Kamada, Asahiro, Morishita, Hideki, Kobara, Masafumi, Ono, Keiichi, Okano, Tsutomu, Masaki
Publikováno v:
Anticancer research. 42(8)
Anti-inflammatory drugs, such as aspirin, have attracted attention as anticancer agents that can be applied to standard chemotherapy for pancreatic cancer. This study aimed to examine the antitumour effects and possible fundamental mechanisms of aspi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2cfcb105390119d4c132fbe8dd15d629
https://pubmed.ncbi.nlm.nih.gov/35896270
https://pubmed.ncbi.nlm.nih.gov/35896270
Autor:
MASAHIRO HIRATA, KOJI FUJITA, SHINTARO FUJIHARA, TAKAAKI MIZUO, RYOTA NAKABAYASHI, TOSHIAKI KONO, DAISUKE NAMIMA, NAOKI FUJITA, HIROKI YAMANA, HIDEKI KAMADA, JOJI TANI, HIDEKI KOBARA, KUNIHIKO TSUTSUI, YOKO MATSUDA, MASAFUMI ONO, TSUTOMU MASAKI
Publikováno v:
In Vivo; Jan/Feb2022, Vol. 36 Issue 1, p94-102, 9p
Publikováno v:
Endoscopy. 52:E221-E222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e461eb75b45b6d611cb7c16fc028cd
https://doi.org/10.1055/a-1073-7480
https://doi.org/10.1055/a-1073-7480
Autor:
MASAHIRO HIRATA, KOJI FUJITA, SHINTARO FUJIHARA, TAKAAKI MIZUO, RYOTA NAKABAYASHI, TOSHIAKI KONO, DAISUKE NAMIMA, NAOKI FUJITA, HIROKI YAMANA, HIDEKI KAMADA, JOJI TANI, HIDEKI KOBARA, KUNIHIKO TSUTSUI, YOKO MATSUDA, MASAFUMI ONO, TSUTOMU MASAKI
Publikováno v:
In Vivo
Background/aim: The promoter region of the telomerase reverse transcriptase (TERT) gene is a regulatory element capable of affecting TERT expression, telomerase activity, and telomerase length. Mutations within the TERT promoter region are the most c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3509fb3ce9fb8f736e9600c559a3b79
http://id.nii.ac.jp/1731/00009528/
http://id.nii.ac.jp/1731/00009528/
